APA

Graux C., Sonet A., Maertens J., Duyster J., Greiner J., Chalandon Y., Martinelli G., Hess D., Heim D., Giles F. J., Kelly K. R., Gianella-Borradori A., Longerey B., Asatiani E., Rejeb N. & Ottmann O. G. (20131017). A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. : Leukemia research.

Chicago

Graux Carlos, Sonet Anne, Maertens Johan, Duyster Justus, Greiner Jochen, Chalandon Yves, Martinelli Giovanni, Hess Dagmar, Heim Dominik, Giles Francis J, Kelly Kevin R, Gianella-Borradori Athos, Longerey Blandine, Asatiani Ekaterine, Rejeb Narmyn and Ottmann Oliver G. 20131017. A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. : Leukemia research.

Harvard

Graux C., Sonet A., Maertens J., Duyster J., Greiner J., Chalandon Y., Martinelli G., Hess D., Heim D., Giles F. J., Kelly K. R., Gianella-Borradori A., Longerey B., Asatiani E., Rejeb N. and Ottmann O. G. (20131017). A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. : Leukemia research.

MLA

Graux Carlos, Sonet Anne, Maertens Johan, Duyster Justus, Greiner Jochen, Chalandon Yves, Martinelli Giovanni, Hess Dagmar, Heim Dominik, Giles Francis J, Kelly Kevin R, Gianella-Borradori Athos, Longerey Blandine, Asatiani Ekaterine, Rejeb Narmyn and Ottmann Oliver G. A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. : Leukemia research. 20131017.